XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Combined and Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 83,667 $ 215,434
Accounts receivable, net of allowance for doubtful accounts 305 91,533
Prepaid expenses and other receivables 1,019,883 4,460,818
Inventories
Marketable securities 4,532,296 75,000
Assets of discontinued operations 15,915,997
Total current assets 5,636,151 20,758,782
OTHER ASSETS:    
Property and equipment, net 620,075 59,096
Intangible assets, net 1,108,407 628,639
Assets of discontinued operations 24,440,532
Total other assets 1,728,482 25,128,267
Total assets 7,364,633 45,887,049
CURRENT LIABILITIES:    
Short-term bank loans 4,676,184
Convertible note payable, net of unamortized debt discount 838,571 710,504
Accounts payable 516,341 309,680
Accrued expenses 279,941 34,319
Due to related parties 2,365,504 6,132,847
Income taxes payable 6,802 27,446
Liabilities of discontinued operations 8,604,463
Total current liabilities 8,683,343 15,819,259
LONG-TERM LIABILITIES:    
Long-term bank loans 4,981,361
Total liabilities 13,664,704 15,819,259
Commitments and contingencies
STOCKHOLDERS' (DEFICIT) EQUITY:    
Common stock ($0.001 par value; 200,000,000 shares authorized; 199,418,592 and 188,506,928 shares issued and outstanding at December 31, 2019 and 2018, respectively) 199,418 188,507
Common stock to be issued 7,018,942 7,018,942
Additional paid-in capital 53,699,861 58,452,131
Accumulated deficit (66,300,687) (40,099,942)
Statutory reserve 2,352,592
Accumulated other comprehensive income 42,597 2,695,362
Total stockholders' (deficit) equity (5,339,869) 30,607,592
Non-controlling interest (960,202) (539,802)
Total stockholders’ (deficit) equity (6,300,071) 30,067,790
Total liabilities and stockholders’ (deficit) equity 7,364,633 45,887,049
Series A Preferred stock    
STOCKHOLDERS' (DEFICIT) EQUITY:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; Series A Preferred stock ($0.001 par value; 50,000,000 and 0 shares authorized; 0 and 0 issued and outstanding at December 31, 2019 and 2018, respectively)